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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1945Genetics of ARVC: A Practical Guide for PhysiciansFrank I. Marcus, Sue Edson, Jeffrey A. Towbin
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically transmitted
disease; however, the genetics are complex. Five causative desmosomal genes have been
identified, but only 30% to 50% of patients with ARVC have one of these gene
abnormalities. It is assumed that there are other genes not yet identified. Patients with
ARVC may have more than one genetic defect in the same gene (compound heterozygosity)
or in a second complementary gene (digenic heterozygosity). Clinical genetic testing is
commercially available and can be beneficial for first-degree family members of an individual
with ARVC if there is a known genetic abnormality in the affected individual.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY1949Ischemic Post-Conditioning Provides a Renoprotective Effect During PCISpyridon Deftereos, Georgios Giannopoulos, Vasileios Tzalamouras, Konstantinos Raisakis,
Charalambos Kossyvakis, Andreas Kaoukis, Vasiliki Panagopoulou, Sofia Karageorgiou, Dimitrios Avramides,
Konstantinos Toutouzas, George Hahalis, Vlassios Pyrgakis, Antonis S. Manolis, Dimitrios Alexopoulos,
Christodoulos Stefanadis, Michael W. Cleman
Deftereos and colleagues studied the efficacy of remote ischemic post-conditioning (RIC) for
preventing acute kidney injury (AKI) in patients undergoing percutaneous coronary
intervention (PCI). Eligible patients were randomized to receive RIC by cycles of inflation
and deflation of the stent balloon during PCI or a sham procedure (controls). The rate of
AKI, defined as an increase of 0.5 mg/dl or 25% in serum creatinine, was 12% versus
30% in controls. The 30-day rate of death or re-hospitalization for any cause was 22% in
controls versus 12% in RIC patients. RIC during PCI appears to confer protection against
AKI and produce improved 30-day clinical outcomes.(continued on page A-23)
MAY 14, 2013 (continued) A-23CARDIOMETABOLIC RISK1956Effect of Lipid-Lowering Therapy on EATNikolaos Alexopoulos, Bekir H. Melek, Chesnal D. Arepalli, Gregory-Randell Hartlage, Zhengjia Chen,
Sungjin Kim, Arthur E. Stillman, Paolo Raggi
Epicardial adipose tissue (EAT) has been associated with coronary artery disease severity and
outcomes. Alexopoulos and colleagues evaluated the effect of intensive or moderate statin
therapy on EAT volume. Hyperlipidemic post-menopausal women were randomized to
intensive or moderate statin therapy and underwent cardiac computed tomography scans at
the start and end of the trial period. At the end of follow-up, EAT regressed more in the
intensive than in the moderate therapy groups (3.1  0.98%). The authors are not sure
whether these results are due to low-density lipoprotein lowering or to the anti-inflammatory
actions of statins.Editorial Comment: Matthew J. Budoff, p. 1962CARDIOMETABOLIC RISK1964Slower Gait Speed Predicts Higher Mortality After Myocardial InfarctionYasushi Matsuzawa, Masaaki Konishi, Eiichi Akiyama, Hiroyuki Suzuki, Naoki Nakayama,
Masayoshi Kiyokuni, Shinichi Sumita, Toshiaki Ebina, Masami Kosuge, Kiyoshi Hibi, Kengo Tsukahara,
Noriaki Iwahashi, Mitsuaki Endo, Nobuhiko Maejima, Kenichiro Saka, Katsutaka Hashiba, Kozo Okada,
Masataka Taguri, Satoshi Morita, Seigo Sugiyama, Hisao Ogawa, Hironobu Sashika, Satoshi Umemura,
Kazuo Kimura
Matsuzawa and colleagues performed a prospective observational study of gait speed in 472
patients with recent ST-segment-elevation myocardial infarction (STEMI) to determine the
additional prognostic value of gait speed. Gait speeds were measured using a 200-m course
before discharge. Cardiovascular events increased across decreasing tertiles of gait speed
(fastest tertile: 3.2%, middle tertile: 13%, slowest tertile: 37%). Cox proportional hazards
analysis showed that gait speed was a significant and independent predictor of cardiovascular
events. These results show a strong relationship between gait speed measured shortly after
STEMI and subsequent cardiovascular risk.(continued on page A-28)
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1973Early Increase in Hemoglobin Associated With Improved
Outcomes in Patients With ADHFPeter van der Meer, Douwe Postmus, Piotr Ponikowski, John G. Cleland, Christopher M. O’Connor,
Gad Cotter, Marco Metra, Beth A. Davison, Michael M. Givertz, George A. Mansoor, John R. Teerlink,
Barry M. Massie, Hans L. Hillege, Adriaan A. Voors
While anemia is related to poor outcomes in patients with heart failure, an increase in
hemoglobin during hospitalization might be a sign of effective decongestion. van der Meer
and colleagues performed a post-hoc analysis of the PROTECT study in patients with acute
decompensated heart failure (AHF) and mild-to-moderate impaired renal function. One-half
of subjects were anemic at baseline. Hemoglobin increased in two-thirds and was associated
with more weight loss, but also a deterioration in renal function. The 6-month mortality was
lower in those who had a rapid increase in hemoglobin during the first week.Editorial Comment: Akshay S. Desai, p. 1982HEART FAILURE
1985Beneficial Remodeling Occurs Quickly With
Continuous-Flow LVAD UnloadingStavros G. Drakos, Omar Wever-Pinzon, Craig H. Selzman, Edward M. Gilbert, Rami Alharethi,
Bruce B. Reid, Abdulfattah Saidi, Nikolaos A. Diakos, Sandi Stoker, Erin S. Davis, Matthew Movsesian,
Dean Y. Li, Josef Stehlik, Abdallah G. Kfoury, for the UCAR (Utah Cardiac Recovery Program) Investigators
The magnitude, timeline, and sustainability of beneficial cardiac remodeling produced by
continuous-flow left ventricular assist device (LVAD) are unknown. Drakos and colleagues
prospectively followed 80 patients after implantation of a continuous-flow LVAD and
performed serial echocardiograms during the first year. After 6 months of LVAD unloading,
34% of patients had a relative left ventricular ejection fraction (LVEF) increase above 50%
and 19% of patients achieved an LVEF 40%. LV systolic function improved as early as 30
days. LV end-diastolic and end-systolic volumes decreased as early as 30 days post-LVAD
unloading. Continuous-flow LVAD unloading induced in a subset of patients, both ischemic
and nonischemic, early improvement in myocardial structure and systolic and diastolic
function that was largely completed within 6 months, with no evidence of subsequent
regression.
Editorial Comment: Eric Adler, Jorge Silva Enciso, p. 1995(continued on page A-30)
MAY 14, 2013 (continued) A-30w
(
EHEART RHYTHM DISORDERS1998Rivaroxaban Appears as Safe as Warfarin for CardioversionJonathan P. Piccini, Susanna R. Stevens, Yuliya Lokhnygina, Ganesh R. Patel, Jonathan L. Halperin,
Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Christopher C. Nessel,
Kenneth W. Mahaffey, Keith A. A. Fox, Robert M. Califf, Gu¨nter Breithardt, for the ROCKET AF
Steering Committee & Investigators
There are limited data on outcomes following cardioversion or catheter ablation in atrial
fibrillation (AF) patients treated with factor Xa inhibitors. Piccini and colleagues compared
the outcomes following electrical cardioversion, pharmacologic cardioversion, or AF ablation
for patients in the ROCKET AF trial, where subjects were randomized to either warfarin or
rivaroxaban. There were approximately 400 of these procedures. There was no evidence of a
difference between rivaroxaban or warfarin, for hospitalization rates, rates of stroke or systemic
embolism, or death from any cause.CARDIAC IMAGING
2007Increased 99mTc-MIBI Washout Reflects May
Reflect Mitochondrial Dysfunction in DCM PatientsDaisuke Hayashi, Satoru Ohshima, Satoshi Isobe, Xian Wu Cheng, Kazumasa Unno, Hidehito Funahashi,
Norihiro Shinoda, Takahiro Okumura, Akihiro Hirashiki, Katsuhiko Kato, Toyoaki Murohara
Hayashi and colleagues investigated whether the 99mTc-sestamibi (MIBI) washout rate (WR)
ould predict mitochondrial damage and myocardial dysfunction in dilated cardiomyopathy
DCM) patients. A total of 20 DCM patients underwent myocardial 99mTc-MIBI
scintigraphy, cardiac catheterization with biopsy, and dobutamine stress echocardiography.
WR significantly correlated with the percentage change in LV dP/dtmax from baseline to
peak dobutamine stress. Those with higher WR had more mRNAs for mitochondrial
electron transport-related enzymes. Electron microscopy revealed significant correlations
between WR and the severity of mitochondrial damage and glycogen accumulation. These
results show that 99mTc-MIBI WR can identify DCM patients with mitochondrial damage.ditorial Comment: H. William Strauss, p. 2018
